Indian Online Pharmaceuticals Market Outlook 2022 Market Report; Launched via MarketResearchReports.com

Online pharmacies are anticipated to turnaround as one of the most promising healthcare services in Indian context by providing easy and affordable access to medicines. The report “Indian Online Pharmaceuticals Market Outlook 2022” provides in-depth analysis of the current scenario, detailed market outlook of Indian online pharmaceutical market with coverage on major market players, business models and regulatory framework. Market outlook for overall Indian pharmaceutical as well as online pharmaceutical market has been provided for the period 2017-22 in the report.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in Indian online pharmaceutical market. The report has been segmented as following:-

Companies Coverage

  • Apollo Pharmacy
  • 1MG
  • PM Healthcare
  • Netmeds

Technological prowess in healthcare industry has empowered consumers with emergence of E-pharmacy. E-pharmacies can aggregate supplies by having simultaneous access to inventories of multiple pharmacies which leads to availability of hard-to-find medicines at finger click. This has led to phenomenal increase in accessibility of healthcare services to far-flung areas in otherwise ubiquitous pharmaceutical industry in the country. Various E-pharmacies business models have been operating in the nation such as Inventory Led model, Hub and Spoke model, Hybrid Model and Local-Channel Model. These models have been analyzed in the report in context to Indian market.

Growth of Indian online pharmaceutical market is propelled by surge in internet penetration, convenience provided to consumers, increasing healthcare awareness, government initiatives and rising disposable incomes. However, there are various factors restraining growth of the market which includes lack of proper regulatory framework, opposition from offline retailers, high logistics costs and quality assurance issues. The market is characterized by leading trends such investments in E-Pharmacy and online presence of existing “Brick-and-Mortar” drug retailers.

The report “Indian Online Pharmaceuticals Market Outlook 2022” provides in-depth analysis of the current scenario, detailed market outlook of the Indian online pharmacies market with coverage on market regulations, SWOT analysis and business models existing in the market. Future forecasts of Indian pharmaceuticals market overall and online pharmaceuticals has been provided in the report. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating Indian online pharmaceuticals market include Apollo Pharmacy, 1MG.com, PM Healthcare and Netmeds.com, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in Indian online pharmaceuticals market.

Spanning over 65 pages Indian Online Pharmaceuticals Market Outlook 2022” report covers Executive Summary, Research Methodology, Indian Pharmaceutical Market, Online Pharmaceutical, Indian Online Pharmacy Market Analysis, Market Regulation, SWOT Analysis, Market Dynamics, Competitive Landscape, Company Profiles, Recommendations. This report Covered Companies – Apollo Pharmacy, 1MG, PM Healthcare and Netmeds.

Please visit this link for more details: http://mrr.cm/UY4

For related reports please visit: Pharmaceutical Market Research Reports

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

About Market Research Reports, Inc.

Market Research Reports® Inc. is world’s largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Global Assisted Reproductive Technology Market Outlook 2022 Market Report; Launched via MarketResearchReports.com

The problem of infertility has aggravated globally with rise in advanced maternal age and various other factors. “Global Assisted Reproductive Technology (ART) Market – In Vitro Fertilization, Artificial Insemination and Third Party Assisted ART Market Outlook 2022” provides an in-depth analysis of global Assisted Reproductive Technology (ART) market overall as well as major technologies such as In Vitro Fertilization, Artificial Insemination and Third-Party Assisted ART (Sperm donation, Egg donation, Embryo donation and Surrogates). Market outlook for overall Assisted Reproductive Technology (ART) market as well as aforementioned sub-segments has been provided for the period 2017-22.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global assisted reproductive technology market.

The report has been segmented as following:-

Market Segmentation

  • In Vitro Fertilization
  • Artificial Insemination
  • Third-Party Assisted ART

Geographical Coverage

  • Global
  • Americas
  • Asia Pacific
  • Europe, Middle East & Africa

Companies Coverage

  • Merck & Co., Inc.
  • CooperSurgical, Inc.
  • Irvine Scientific Sales Company, Inc.
  • Vitrolife AB
  • Hamilton Thorne, Inc.,

Infertility is a medical condition characterized by inability to achieve pregnancy. The problem has aggravated in many parts of the world underscoring the need for technological prowess to address the issue. Advancement in medical technology has brought forth Assisted Reproductive Technology (ART) which is acting as saviour for treatment of infertility. ART procedures spans from Invitro Fertilization, Artificial Insemination technologies such as Intrauterine Insemination, Intravaginal Insemination and Intracervical Insemination to third party assisted ART. Adoption rate of ART techniques has been increasing at fast pace globally.

Growth of global Assisted Reproductive Technology (ART) market is primarily attributed to factors such as prevalence of infertility, advanced maternal age, high obesity rates, rising level of alcohol and tobacco consumption, low awareness of fertility problems and favourable reimbursement policies. However, the market faces challenges due to stringent regulatory norms and high treatment cost associated with treatment of infertility. The market is characterized by leading trends such growth in strategic alliances and technological advancement in various procedures pertaining to treatment of infertility using ART.

The report “Global Assisted Reproductive Technology (ART) Market – In Vitro Fertilization, Artificial Insemination and Third Party Assisted ART Market Outlook 2022” provides in-depth analysis of the current scenario, detailed market outlook of the global Assisted Reproductive Technology (ART) market with coverage of major technologies such as In Vitro Fertilization, Artificial Insemination and Third-Party Assisted ART (Sperm donation, Egg donation, Embryo donation and Surrogates). Geographically, the market is segmented into Americas, Asia Pacific and Europe, Middle East & Africa. Future forecasts of ART market overall and across various sub-segments is provided in the report till the year 2022. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global market include Merck & Co., Inc., CooperSurgical, Inc., Irvine Scientific Sales Company, Inc., Vitrolife AB, Hamilton Thorne, Inc., among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global assisted reproductive technology market.

Spanning over 77 pages Global Assisted Reproductive Technology (ART) Market – In Vitro Fertilization, Artificial Insemination and Third Party Assisted ART Market Outlook 2022” report covers Executive Summary, Research Methodology, Assisted Reproductive Technology: Introduction, Assisted Reproductive Technology (ART) Market Analysis, Assisted Reproductive Technology (ART) Market Segmentation, Assisted Reproductive Technology (ART) Regional Analysis, Assisted Reproductive Technology (ART) Market Dynamics, Competitive Landscape, Company Profiles. This report Covered Companies – Merck & Co., Inc., CooperSurgical, Inc., Irvine Scientific Sales Company, Inc., Vitrolife AB, Hamilton Thorne, Inc.

Please visit this link for more details: http://mrr.cm/UYU

For related reports please visit: Assisted Reproductive Technology Market Research Reports

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

About Market Research Reports, Inc.

Market Research Reports® Inc. is world’s largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Global IoT Platforms for Telemedicine market forecast expected to reach $9.3 billion by 2023; Finds New Report

Worldwide markets are poised to achieve significant growth as the digital economy takes hold with IOT Internet of things and all manner of automated medical monitoring processes increase the value of medical care while decreasing the costs.

IoT platforms for healthcare implement use of the digital economy. IoT for Telemedicine depends on infrastructure scalability excellence, which is achieved with a two layer architecture utilizing adapters and processors to manage sensor connectivity.

Healthcare stakeholders include payers, manufacturers, providers and physicians. Telemedicine IoT platforms provide the technology that implement a framework for transition from disjointed care to coordinated care. Platforms permit clinicians to be reactive to change in patient condition, permitting proactive care delivery.

Remote healthcare grew 44% in 2016. The Intel® Health Application Platform helps enable innovation for greater adoption and effectiveness of secure remote patient care solutions. By offering a platform that supports gathering medical data at the edge of the network, devices are enabled that gather and distribute personal medical data securely to any cloud.”

IoT telemedicine platforms growth is brought by the combination the ability to lower the cost of medical care delivery while improving the quality of care dramatically. The IoT telemedicine platforms value goes beyond traditional medical monitoring bringing to the fore, the value of exercise. The value of exercise has been proven and telemedicine is anticipated to be used by exercise clubs to induce members to do more exercise that is beneficial to long term health. The value of supplemental oxygen in improving endurance and building muscles will likely become a part of telemedicine platform initiatives.

IoT Platforms for Telemedicine market forecast indicates that markets at $1.2 billion in 2016 are expected to reach $9.3 billion dollars worldwide by 2023. These represent a very specialized type of analytics systems able to address a wide range of issues that can be newly managed with digitization. Steady growth is anticipated because the IoT platform units are offering breakthrough digital information integration capabilities that further automates a delivery of care to a patient located remotely. Steady growth is anticipated because the IoT platforms are the best device for implementing efficient operations at low cost.

Spanning over 234 pages IoT Platforms for Telemedicine Market Shares, Strategies, and Forecasts, Worldwide, 2017-2023” report covers IoT for Telemedicine Executive Summary, IoT Telemedicine Platforms Market Description and Market Dynamics, IoT for Telemedicine Market Shares and Market Forecasts, IoT for Telemedicine Platform Products, IoT for Telemedicine Research and Technology, IoT for Telemedicine: Companies.

Please visit this link for more details: http://mrr.cm/Uwi

Find all IT and eHealth Reports at: https://www.marketresearchreports.com/it-ehealth

About Market Research Reports, Inc.

Market Research Reports® Inc. is world’s largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Global Medical Software Market Research 2011 – 2022 Market Report; Launched via MarketResearchReports.com

Medical Software is a series of software that used for medical activity. It has one, both or all the function of recording, management and analysis. From increasing staff efficiency and accurate tracking of cases, surgical trays, instruments and implants to patient health management and government regulation, there are always have medical software to fit the needs.

In the report, HeyReport says Hospital dominates the largest Application share in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

By Type

  • EHR/EMR
  • Medical Practice Management
  • Medical CRM
  • Websites and Patient Portals

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Based on Application, the report describes major Application share of regional market. Application mentioned as follows:

  • Hospital
  • Other Health Organization
  • Individual

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

  • eClinicalWorks
  • McKesson
  • Cerner Corp
  • Allscripts
  • Athena Health
  • GE Healthcare
  • Epic Systems Corp
  • Quest Diagnostics (DELL)
  • Optum Health
  • NextGen Healthcare
  • Practice Fusion
  • Greenway Health
  • Carestream Health
  • Merge Healthcare (IBM)
  • Sunquest Information Systems
  • Meditech
  • Compugroup Medical
  • Computer Programs and Systems
  • Lexmark Healthcare
  • Agfa HealthCare
  • Neusoft
  • Winning Health Technology

Spanning over 98 pages Global Medical Software Market Research 2011 – 2022” report covers Market Overview, Industry Chain, Environmental Analysis, Market Segmentation by Type, Market Segmentation by Application, Market Segmentation by Region, Market Competitive, Major Vendors, Conclusion.

Please visit this link for more details: http://mrr.cm/ULX

For related reports please visit: Medical Software Market Research Reports

Find all IT and eHealth Reports at: http://www.marketresearchreports.com/it-ehealth

About Market Research Reports, Inc.

Market Research Reports® Inc. is world’s largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Global and Chinese Tele-Health Monitoring Industry 2017 Market Report; Launched via MarketResearchReports.com

The ‘Global and Chinese Tele-Health Monitoring Industry, 2012-2022 Market Research Report’ is a professional and in-depth study on the current state of the global Tele-Health Monitoring industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tele-Health Monitoring manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail.

In this part, the report presents the company profile, product specifications, capacity, production value, and 2012-2017 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Tele-Health Monitoring industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.

The report then estimates 2017-2022 market development trends of Tele-Health Monitoring industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Tele-Health Monitoring Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2012-2022 global and Chinese Tele-Health Monitoring industry covering all important parameters.

Spanning over 150 pages Global and Chinese Tele-Health Monitoring Industry, 2017 Market Research Report” report covers Introduction of Tele-Health Monitoring Industry, Manufacturing Technology of Tele-Health Monitoring, Analysis of Global Key Manufacturers, 2012-2017 Global and Chinese Market of Tele-Health Monitoring, Market Status of Tele-Health Monitoring Industry, 2017-2022 Market Forecast of Global and Chinese Tele-Health Monitoring Industry, Analysis of Tele-Health Monitoring Industry Chain, Global and Chinese Economic Impact on Tele-Health Monitoring Industry, Market Dynamics of Tele-Health Monitoring Industry, Proposals for New Project, Research Conclusions of Global and Chinese Tele-Health Monitoring Industry.

Please visit this link for more details: http://mrr.cm/UXZ

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare

Other Reports;

Global and Chinese Tele-Health Servers Industry, 2017 Market Research Report – Visit at – http://mrr.cm/UX4

Global and Chinese Telemedicine Industry, 2017 Market Research Report – Visit at – http://mrr.cm/UXo

About Market Research Reports, Inc.

Market Research Reports® Inc. is world’s largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Global Biochips Market is expected to reach $17,851.1 million by 2023; Finds New Report

Biochips come handy as thousands of experiments are performed on a small chip with a solid platform and acts like a mini laboratory. Usage of biochips has increased in the past decade as its application varies from high throughput screening in drug discovery to personalized medicine.

The global biochips market is expected to grow at double digit CAGR to reach $17,851.1 million by 2023. Biochips market is mainly classified into technologies, products, application and end-users. The global biochips market is broadly classified as micro arrays and microfluidics based on technology. Based on products, the market is classified into Instruments, Reagents & Consumables and Software & Services.

Biochips market is segmented on the basis of application as Genomics, Proteomics, Drug discovery, Diagnostics, Food & agricultural testing and others. Genomics application segment is further classified into SNP Genotyping, Gene Expression and Others where as Drug discovery segment is further sub segmented into Target Identification & Validation, HTS (High Throughput screening) and Lead Optimization.

Diagnostics segment is further divided into Cancer diagnostics and other diagnostics. End-Users are further classified into Pharmaceutical & Biotech companies, Academic & Research laboratories, Diagnostic laboratories, CROs (Contract and Research Organizations) and others.

Revolution in the field of genomics, proteomics as well as rapid drug discovery increased the demand for biochips. In addition, increase in diagnosis and treatment of cancer and genetic diseases, approval for personalized medicines and invention of novel technologies in biochips drives the market of biochips. Standardization and quality assurance of biochips, technological ease in handling the biochips especially in the areas of diagnosis and treatment, high cost along with ethical and social issues hinders the market growth.

Lifestyle changes owing to increase in cancer, diabetes and hypertension patients, early diagnosis and treatment of diseases, advancement of biochips with its wide application areas shows that biochip market has vast opportunities in the coming years.

North America accounts for the highest market share in 2016 and followed by Europe. Steep rise in genetic diagnosis, huge corporate outsourcing for drug discovery, increase in personalized medicines and favourable government policies makes U.S. the leader of Biochips market. However, Asian countries especially China and Japan are the fastest growing regions with its growing demand for biochips and increasing research investments. Asia-Pacific grows with a highest CAGR of XX% from 2016 to 2023.

Major players in biochips market include Abbott laboratories (U.S.), Agilent Technologies (U.S.), Becton-Dickinson Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), Fluidigm Corporation (U.S.), GE Healthcare (U.S.), Illumina (U.S.), PerkinElmer, Inc. (U.S.) and Thermo Fisher Scientific, Inc. (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Spanning over 404 pages Biochips (Microarrays/Microfluidics) Global Market – Forecast To 2023” report covers Executive Summary, Introduction, Market Analysis, Biochips Global Market, By Technology, Biochips Global Market, By Products, Biochips Global Market, By Applications, Biochips Global Market, By End-Users, Regional Market Analysis, Competitive Landscape, Major Companies. This Report Covered 123 Companies Few Are – Abbott Laboratories, Agilent Technologies, Becton Dickinson And Company, Biorad Laboratories, Danaher Corporation, Fluidigm Corporation, Ge Healthcare, Illumina, Inc., Perkinelmer, Inc., Thermofisher Scientific.

Please visit this link for more details: http://mrr.cm/Um2

Find all Pharma and Healthcare Technology Reports at: http://www.marketresearchreports.com/pharma-healthcare-technology

About Market Research Reports, Inc.

Market Research Reports® Inc. is world’s largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

The Top 150 Manufacturers Of Point-Of-Care Instruments and Tests; New Report Launched

Did you know?

– As of March 31, 2016, Abaxis, Inc. had 549 full-time employees.

– Peter Koerte is President, Point of Care Diagnostics at Siemens Healthineers.

– Four HemoCue point-of-care tests are performed each second worldwide.

-iLine Microsystems earned the 2016 Frost & Sullivan Enabling Technology Leadership Award.

– With over 80,000 placements in high-acuity settings worldwide and 35 million test cartridges produced annually, Abbott Point Of Care’s i-STAT® System has a global impact on bedside point-of-care testing.

– QuantuMDx Group’s first available test will take the guess work out of warfarin dosage by identifying at the point-of-care, subsets of the population who could develop life-threatening bleeds on the standard dose.

– ChroMedX Corp’s HemoPalm Handheld Blood Analyzer System is the only handheld blood analysis technology which combines Blood Gases and Electrolytes with full CO-Oximetry.

– At 60 seconds for a reading, bioLytical Laboratories’ INSTI® Kit is the fastest HIV diagnostic assay in the world today.

– Arbor Vita Corporation’s flagship point-of-care product – the OncoE6™ Cervical Test – has proven to be the most accurate test available worldwide for detecting cervical cancer.

– On March 7, 2017, Alere Inc. announced that its Alere™ i RSV test, the first molecular test that can be used at the point-of-care to detect RSV (respiratory syncytial virus) infection in children and adults in 13 minutes or less,had been granted CLIA waiver by the FDA.

– As well as developing its own family of products, Philips Handheld Diagnostics is open to collaborating with other healthcare companies to exploit the full potential of its Minicare technology.

– For the fiscal year ended March 31, 2016, Abaxis, Inc. reported revenues from continuing operations of $218.9 million.

– On January 20, 2017 Werfen and its subsidiary Instrumentation Laboratory (IL) announced the acquisition of Accriva Diagnostics.

These are just a tiny sample of the 1,000’s of facts to be found in ‘The Top 150 Manufacturers Of Point-Of-Care Instruments & Tests’.

This unique and comprehensive report identifies and profiles the 150 leading companieswith a focus on point-of-care diagnostics. There is no other report on the market that does this.

The companies profiled in this report are located across the globe from the United States and Europe to India and China. They are the ones with the experience, know-how and resources that enable them to develop, manufacture and market innovative products that can compete effectively in global markets. They range from large companies such as Nova Biomedical Corporation to smaller niche companies such as BioDirection, Inc..

Profile information for each company in ‘The Top 150 Manufacturers Of Point-Of-Care Instruments & Tests’ typically includes:

– Company Contact Information – Address, Telephone and Fax Numbers, Email and Website Addresses

– Key Company Decision Makers – From CEO and Main Board, to Key Senior Managers

– Specialised fields such as Company Description, POC Specialties, Ownership, Number of Employees and Revenue

Report Target Market:

1) Point-Of-Care Manufacturing Companies

Usage: competitive/financial analysis and strategic partner/alliance identification.

2) Suppliers

‘The Top 150 Manufacturers Of Point-Of-Care Instruments & Tests’ is perfect for suppliers of raw materials, technology and services to identify top potential customers.

3) Distributors

This report is ideal for distributors of point-of-care instruments and tests to identify the leading manufacturers with the best products.

4) Industry Associations:

‘The Top 150 Manufacturers Of Point-Of-Care Instruments & Tests’ is a useful reference tool for in-vitro diagnosticsindustry associations.

Note: Most people will be aware of some of the major manufacturers of point-of-care instruments and tests such as EKF Diagnostics, PTS Diagnostics and SD Biosensor, Inc. but this major new report looks at all 150 of the top companies – companies like:

– Biosensia Ltd. – Founded in 2009 and headquartered in Dublin, Ireland, Biosensiais a science focused, venture backed business established specifically to develop and exploit its novel and proprietary technology, RapiPlex.RapiPlex is a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results.Itcomprises a disposable assay cartridge and a small table top instrument, making it possible to transition complex immunoassays from the centralised reference laboratory to a doctor’s office or patient’s bedside, facilitating near patient care without compromising analytical performance.The Company’s aim is to make RapiPlex a method of choice for testing multiple analytes in a matter of minutes. Biosensiais interested in exploring product commercialisation under license agreement. It has already signed two development agreements with external partners for products for TB triage and for the monitoring of systemic Lupus and discussions are ongoing in severalother areas including sepsis and infectious disease panels. The Company is led by Niamh O’Luanaigh, Chief Operating Officer.

– Sarissa Biomedical Limited – Sarissa Biomedical’s patented technology delivers a step change in enzymatic biosensor sensitivity and selectivity to detect and measure biomarkers in finger-prick blood samples within minutes, using low cost, single use biosensors and handheld readers. This new generation of biosensors is set to transform emergency clinical care, creating point-of-care diagnostic solutions not previously possible. The Company’s first application is stroke and it expects to make a CE marked product available during 2017. Sarissa Biomedical is working on other diagnostic applications in several major disease areas such as TBI, heart attacks and sepsis. The Company was founded in 2002 and is headquartered in Coventry, United Kingdom. Dr Everard Mascarenhas is Sarissa Biomedical’s Chief Executive Officer.

– Zenosense, Inc.-Zenosense’s primary focus, through their joint venture ownership in MIDS Medical Ltd., is the development of a cost-effective, hand-held, point-of-care, rapid cardiac diagnostic device, MIDS Cardiac™.MIDS Cardiac™ enables the rapid detection of very low levels of cardiac markers with a primary focus on troponin I and T. The device is designed to equal or exceed gold standard laboratory levels of accuracy, at the point-of-care. It is intended to be used with a minimum of training by any ER nurse or by paramedics at the scene. The Companybelieves that MIDS Cardiac™ will revolutionise the diagnosis and management of suspected Acute Myocardial Infarction (AMI), that it will be in universal demand and that it will rapidly penetrate a multi-billion dollar market.Zenosense was founded in 2008, is headquartered in Valencia, Spain and is led by Carlos Gil, Chief Executive Officer.

Report data field structure is as follows:

– Company Name

– Address

– Telephone

– Fax

– Email

– Website

– Year Established

– Number of Employees

– Key Executives

– Company Description

– Products

– POC Specialties

– Revenue ($U.S. million)

– Location Status

– Ownership

– Stock Exchange/Ticker Symbol

– Parent Company Name

Publisher is one of the world’s leading companies in life sciences publishing. It has a large portfolio of best-selling reports spanning diagnostics, pharmaceuticals, biotechnology and medical devices. It’s customers include most of the world’s major companies in these sectors e.g. Abbott Laboratories, ACON Laboratories, Alcon, Alere, Allergan, Aurobindo Pharma, Axis-Shield, Baxter, Bayer, B. Braun, BD, Biomerieux, Biomet, Boditech Med, Boehringer Ingelheim, CareFusion, Covance, Covidien, C.R. Bard, Edwards Lifesciences, EKF Diagnostics, Fresenius, GE Healthcare, Genzyme, HemoCue, Intuitive Surgical, Ipsen, Johnson & Johnson, Medtronic, Merit Medical Systems, Millipore, Mölnlycke Health Care, Novartis, Paul Hartmann, Philips Medical, Qiagen,Quidel, Siemens Healthcare, Smith & Nephew, Synthes, Teleflex, Teva, Tosoh, Zentiva etc.. Publisher also counts many multinational financial services, law and management consulting firms such as Bain & Company, McKinsey & Company and The Boston Consulting Group among its customers.

Publisher currently has customers in some forty countries across the globe e.g. Austria, Australia, Belgium, Brazil, Canada, Cyprus, Czech Republic, Denmark, France, Germany, Finland, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luxembourg, Malta, Mauritius, Netherlands, Pakistan, Peru, Portugal, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, United Kingdom, and the United States.

Publisher’ reports help you make informed decisions about the markets and organisations that affect your business.

– Learn more about your target markets and target companies

– Top level research on all the major players in a market

– See which organisations dominate your major markets

– Get detailed information on particular organisations

Please visit this link for more details: http://mrr.cm/UWP

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

About Market Research Reports, Inc.

Market Research Reports® Inc. is world’s largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Immune Checkpoints Activators – Competitive Landscape, Technology and Pipeline Analysis, 2017 Market Report; Launched via MarketResearchReports.com

Immune Checkpoints Activators- Competitive Landscape, Technology and Pipeline Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the marketed and pipeline drugs that fall under Immune Checkpoints Activators. This report provides information on the therapeutic development based on Immune Checkpoints Activators mechanism of action dealing with around 20+ active pipeline drugs.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Report contains the development and sale activities for marketed drugs. Publisher’s Report also assesses the Immune Checkpoints Activators therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. The report also covers the information for 20+ active companies involved in the therapeutic development of the products.

Scope

  • The report provides competitive pipeline landscape of Immune Checkpoints Activators
  • The report provides the marketed drugs information including its sales, development activities and details of patent expiry
  • The report provides the insight of current and future market for Immune Checkpoints Activators
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Immune Checkpoints Activators pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Immune Checkpoints Activators and also provide company profiling
  • The report also gives the information of dormant pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Reasons to Buy

  • Identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage
  • Complete MOA intelligence and complete understanding over therapeutics development for Immune Checkpoints Activators
  • Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
  • Devise corrective measures for pipeline projects by understanding Immune Checkpoints Activators pipeline depth and focus of Indication therapeutics
  • Developing strategic initiatives to support your drug development activities.
  • Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
  • Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
  • Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Spanning over 149 pages, 20 Tables and 20 Figures Immune Checkpoints Activators – Competitive Landscape, Technology and Pipeline Analysis, 2017” report covers Executive Summary, Immune checkpoints Activator Overview, ImmuneCheck Activators Analysis, ImmuneCheck Activators- Market Analysis, Market Drivers, ImmuneCheck Activators – Pipeline Analysis, Comparative Analysis, Therapeutic Assessment, Appendix.

For more information Visit at: http://mrr.cm/3FY

Find all Diseases Reports at: http://www.marketresearchreports.com/diseases

About Market Research Reports, Inc.

Market Research Reports, Inc. is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Global Internet of Things (IoT) Healthcare Market Outlook 2020; New Report Launched

Internet of Things refers to ubiquitous network of interconnected objects capable of information storage and exchange through the use of embedded sensors, actuators, and other devices. The IoT is a revolutionary technology which facilitates data-driven decision making by monitoring and managing objects in real-time.

The proliferation of IoT in healthcare segment in anticipated witnessing surge in demand with use of technologically advanced medical devices. Adoption of IoT services in healthcare leads to introduction of technologically advanced connected medical devices which help in remote patient monitoring and clinical care in general. Furthermore, it provides new possibilities for personalized healthcare with the use of leading healthcare applications such as Health tracker apps, Healthcare wearable, Telemonitoring and smarthomes, Electronic health records, etc.

IoT Healthcare market can be broadly divided into three components – Medical devices, Systems & software, and Services. Software & system segment dominates global IoT Healthcare market. Some of the leading technologies facilitating integration of IoT in healthcare domain that are covered in the report are RFID, mHealth, Telemedicine and Bluetooth Low Energy. Extensive coverage on actual and forecasted market analysis of IoT Healthcare, its components and technologies are provided in the report.

Growth of the market is fueled by increasing prevalence of chronic diseases, rising number of geriatric population globally and higher efficiency provided by use of IoT in healthcare. Other factors such as availability of high speed internet and favorable government regulatory policies are also expected to boost market growth. However, certain limitations of IoT in healthcare segment poses challenge to growth of the industry. Some of these are lack of interoperability, privacy and security concerns and lack of regulatory oversight.

The report also covers section on major trends and industry developments in recent years which influences industry dynamics. Companies operating in the segment, both medical device manufacturers and IT companies are developing innovative products and services such as, Cognitive solution to diabetes management by Medtronic and IBM, Medical data exchange by Cisco and Philips Medical dispensing service, amongst others.

The report highlights key players operating in IoT healthcare market. These include Medtronic PLC, GE Healthcare and Philips Healthcare. These players have been profiled based on attributes such as business overview, product segments, financial and business strategies. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. The report includes relevant information which can be fruitful for clients in evaluating opportunities in global IoT healthcare market.

Spanning over 63 pages, 7 Tables and 23 Figures Global Internet of Things (IoT) Healthcare Market Outlook 2020” report covers Executive Summary, Research Methodology, Internet of Things, IoT Healthcare Industry, Global IoT Healthcare Market Analysis, Global IoT Healthcare Market Segment Analysis, Global IoT Healthcare Trends & Industry Developments, Global IoT Healthcare Market Dynamics, Competitive Landscape, Company Profiles. This report Covered Companies – GE Healthcare, Medtronic PLC, Philips Healthcare.

For more information Visit at: http://mrr.cm/3QM

Find all IT and eHealth Reports at: http://www.marketresearchreports.com/it-ehealth

About Market Research Reports, Inc.

Market Research Reports, Inc. is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Global Surgery Partnering 2010 to 2016; New Report Launched

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies.

  • Trends in partnering deals
  • Top deals by value
  • Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual bladder cancer deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2010 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2010 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Benefits

Global Therapy Partnering Terms and Agreements since 2010 report provides the reader with the following key benefits:

  • In-depth understanding of deal trends since 2010
  • Access to headline, upfront, milestone and royalty data
  • Comprehensive access to multiple deals entered into by the world’s biopharma companies since 2010
  • Insight into key deal terms included in contracts, where disclosed
  • Understand the key deal terms companies have agreed in deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Spanning over 200 pages Global Surgery Partnering 2010 to 2016” report covers Executive Summary, Therapypartnering trends in numbers, Most active dealmakers, Partnering deals directory, Partnering deals with a contract document, M&A in numbers, M&A deals directory, Financing in numbers, Financing deals directory.

For more information Visit at: http://mrr.cm/333

Related Reports;

Global Transplantation Partnering 2010 to 2016 – Visit at – http://mrr.cm/33U

Global AIDS Partnering 2010 to 2016 – Visit at – http://mrr.cm/33w

Global Allergy Partnering 2010 to 2016 – Visit at – http://mrr.cm/33i

Global Hepatitis Partnering 2010 to 2016 – Visit at – http://mrr.cm/335

About Market Research Reports, Inc.

Market Research Reports, Inc. is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.